Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 7/2012

01-09-2012 | Erratum

Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample

Auteurs: Alexandra L. Quittner, Gregory S. Sawicki, Ann McMullen, Lawrence Rasouliyan, David J. Pasta, Ashley Yegin, Michael W. Konstan

Gepubliceerd in: Quality of Life Research | Uitgave 7/2012

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

The psychometric properties of a health-related quality of life (HRQOL) instrument, the Cystic Fibrosis Questionnaire-Revised (CFQ-R), were evaluated in a national, US sample of patients with cystic fibrosis (CF). This is the first psychometric evaluation of the revised version of this instrument.

Methods

The Epidemiologic Study of CF is a national, US multicenter longitudinal cohort study containing CFQ-R and health outcomes data. Developmentally appropriate versions of the CFQ-R were available from 7,330 patients aged 6–70 years and a proxy version from 2,728 parents of school-age children. The CFQ-R was completed during a “stable” or “sick” visit before recording health outcomes such as weight, lung function, and pulmonary exacerbations.

Results

There were few floor and ceiling effects and strong internal consistency (Cronbach alpha ≥0.70) for most scales. The CFQ-R consistently discriminated between patients seen for sick-versus-well visits, and among stages of disease severity based on lung function. As predicted, women with CF reported worse HRQOL than men on scales not related to body image and weight. Strong parent–child agreement was found on scales measuring observable behaviors (respiratory symptoms). Convergence between CFQ-R scales and health outcomes provided evidence of construct validity.

Conclusions

The CFQ-R demonstrated robust psychometric properties and consistent associations with health outcomes in a large national, US sample. Normative data are available to aid in interpretation.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
2.
go back to reference Fayers, P., & Hays, R. (Eds.). (2005). Assessing quality of life in clinical trials: Methods, practice (2nd ed.). New York: Oxford University Press. Fayers, P., & Hays, R. (Eds.). (2005). Assessing quality of life in clinical trials: Methods, practice (2nd ed.). New York: Oxford University Press.
3.
go back to reference Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., Oermann, C. M., McCoy, K. S., Montgomery, A. B., et al. (2009). Efficacy and safety of inhaled Aztreonam Lysine for airway Pseudomonas in cystic fibrosis. Chest, 135(5), 1223–1232. PubMedCrossRef Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., Oermann, C. M., McCoy, K. S., Montgomery, A. B., et al. (2009). Efficacy and safety of inhaled Aztreonam Lysine for airway Pseudomonas in cystic fibrosis. Chest, 135(5), 1223–1232. PubMedCrossRef
4.
go back to reference Goss, C. H., & Quittner, A. L. (2007). Patient-reported outcomes in cystic fibrosis. Proceedings of the American Thoracic Society, 4(4), 378–386. PubMedCrossRef Goss, C. H., & Quittner, A. L. (2007). Patient-reported outcomes in cystic fibrosis. Proceedings of the American Thoracic Society, 4(4), 378–386. PubMedCrossRef
5.
go back to reference Quittner, A. L., Modi, A., & Cruz, I. (2008). Systematic review of health-related quality of life measures for children with respiratory conditions. Paediatric Respiratory Reviews, 9(3), 220–232. PubMedCrossRef Quittner, A. L., Modi, A., & Cruz, I. (2008). Systematic review of health-related quality of life measures for children with respiratory conditions. Paediatric Respiratory Reviews, 9(3), 220–232. PubMedCrossRef
6.
go back to reference Quittner, A. L., Modi, A. C., Wainwright, C., Otto, K., Kirihara, J., & Montgomery, A. B. (2009). Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest, 135(6), 1610–1618. PubMedCrossRef Quittner, A. L., Modi, A. C., Wainwright, C., Otto, K., Kirihara, J., & Montgomery, A. B. (2009). Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest, 135(6), 1610–1618. PubMedCrossRef
7.
go back to reference Quittner, A. L., Buu, A., Messer, M. A., Modi, A. C., & Watrous, M. (2005). Development and validation of the cystic fibrosis Questionnaire in the United States: A health-related quality-of-life measure for cystic fibrosis. Chest, 128(4), 2347–2354. PubMedCrossRef Quittner, A. L., Buu, A., Messer, M. A., Modi, A. C., & Watrous, M. (2005). Development and validation of the cystic fibrosis Questionnaire in the United States: A health-related quality-of-life measure for cystic fibrosis. Chest, 128(4), 2347–2354. PubMedCrossRef
8.
go back to reference Kaplan, R. M., Anderson, J. P., Wu, A. W., Mathews, W. C., Kozin, F., & Orenstein, D. (1989). The quality of well-being scale. Applications in AIDS, cystic fibrosis, and arthritis. Medical Care, 27(3 Suppl), S27–S43. PubMedCrossRef Kaplan, R. M., Anderson, J. P., Wu, A. W., Mathews, W. C., Kozin, F., & Orenstein, D. (1989). The quality of well-being scale. Applications in AIDS, cystic fibrosis, and arthritis. Medical Care, 27(3 Suppl), S27–S43. PubMedCrossRef
9.
go back to reference Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483. PubMedCrossRef Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483. PubMedCrossRef
10.
go back to reference Palermo, T. M., Long, A. C., Lewandowski, A. S., Drotar, D., Quittner, A. L., & Walker, L. S. (2008). Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology. Journal of Pediatric Psychology, 33, 983–996. PubMedCrossRef Palermo, T. M., Long, A. C., Lewandowski, A. S., Drotar, D., Quittner, A. L., & Walker, L. S. (2008). Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology. Journal of Pediatric Psychology, 33, 983–996. PubMedCrossRef
11.
go back to reference Scoggins, J. F., & Patrick, D. L. (2009). The use of patient-reported outcomes instruments in registered clinical trials: Evidence from ClinicalTrials.gov. Contemporary Clinical Trials, 30(4), 289–292. PubMedCrossRef Scoggins, J. F., & Patrick, D. L. (2009). The use of patient-reported outcomes instruments in registered clinical trials: Evidence from ClinicalTrials.gov. Contemporary Clinical Trials, 30(4), 289–292. PubMedCrossRef
12.
go back to reference Cystic Fibrosis Foundation Patient Registry. (2007). Annual data report 2007. Bethesda, MD: Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry. (2007). Annual data report 2007. Bethesda, MD: Cystic Fibrosis Foundation.
13.
go back to reference Quittner, A. L., Barker, D. H., Snell, C., Grimley, M. E., Marciel, K. K., & Cruz, I. (2008). Prevalence and impact of depression in cystic fibrosis. Current Opinion in Pulmonary Medicine, 14(6), 582–588. PubMedCrossRef Quittner, A. L., Barker, D. H., Snell, C., Grimley, M. E., Marciel, K. K., & Cruz, I. (2008). Prevalence and impact of depression in cystic fibrosis. Current Opinion in Pulmonary Medicine, 14(6), 582–588. PubMedCrossRef
14.
go back to reference Smith, B. A., Modi, A. C., Quittner, A. L., & Wood, B. L. (2010). Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatric Pulmonology, 45(8), 756–763. PubMedCrossRef Smith, B. A., Modi, A. C., Quittner, A. L., & Wood, B. L. (2010). Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatric Pulmonology, 45(8), 756–763. PubMedCrossRef
15.
go back to reference Rosenfeld, M., Davis, R., FitzSimmons, S., Pepe, M., & Ramsey, B. (1997). Gender gap in cystic fibrosis mortality. American Journal of Epidemiology, 145(9), 794–803. PubMedCrossRef Rosenfeld, M., Davis, R., FitzSimmons, S., Pepe, M., & Ramsey, B. (1997). Gender gap in cystic fibrosis mortality. American Journal of Epidemiology, 145(9), 794–803. PubMedCrossRef
16.
go back to reference Courtney, J. M., Bradley, J., McCaughan, J., O’Connor, T. M., Shortt, C., Bredin, C. P., et al. (2007). Predictors of mortality in adults with cystic fibrosis. Pediatric Pulmonology, 42(6), 525–532. PubMedCrossRef Courtney, J. M., Bradley, J., McCaughan, J., O’Connor, T. M., Shortt, C., Bredin, C. P., et al. (2007). Predictors of mortality in adults with cystic fibrosis. Pediatric Pulmonology, 42(6), 525–532. PubMedCrossRef
17.
go back to reference Briesacher, B. A., Quittner. A. L., Fouayzi, H., Zhang, J., & Swensen, A. (2011). Nationwide trends in the medical care costs of privately- insured patients with cystic fibrosis, 2001– 2007. Pediatric Pulmonology (in press). Briesacher, B. A., Quittner. A. L., Fouayzi, H., Zhang, J., & Swensen, A. (2011). Nationwide trends in the medical care costs of privately- insured patients with cystic fibrosis, 20012007. Pediatric Pulmonology (in press).
18.
go back to reference Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009). High treatment burden in adults with cystic fibrosis: Challenges to disease self-management. Journal of Cystic Fibrosis, 8(2), 91–96. PubMedCrossRef Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009). High treatment burden in adults with cystic fibrosis: Challenges to disease self-management. Journal of Cystic Fibrosis, 8(2), 91–96. PubMedCrossRef
19.
go back to reference Modi, A. C., & Quittner, A. L. (2003). Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. Journal of Pediatric Psychology, 28(8), 535–545. PubMedCrossRef Modi, A. C., & Quittner, A. L. (2003). Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. Journal of Pediatric Psychology, 28(8), 535–545. PubMedCrossRef
20.
go back to reference Henry, B., Aussage, P., Grosskopf, C., & Goehrs, J. M. (2003). Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Quality of Life Research, 12(1), 63–76. PubMedCrossRef Henry, B., Aussage, P., Grosskopf, C., & Goehrs, J. M. (2003). Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Quality of Life Research, 12(1), 63–76. PubMedCrossRef
21.
go back to reference Quittner, A. L., Sweeny, S., Watrous, M., Munzenberger, P., Bearss, K., Gibson Nitza, A., et al. (2000). Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. Journal of Pediatric Psychology, 25(6), 403–414. PubMedCrossRef Quittner, A. L., Sweeny, S., Watrous, M., Munzenberger, P., Bearss, K., Gibson Nitza, A., et al. (2000). Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. Journal of Pediatric Psychology, 25(6), 403–414. PubMedCrossRef
22.
go back to reference McCoy, K. S., Quittner, A. L., Oermann, C. M., Gibson, R. L., Retsch-Bogart, G. Z., & Montgomery, A. B. (2008). Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 178(9), 921–928. PubMedCrossRef McCoy, K. S., Quittner, A. L., Oermann, C. M., Gibson, R. L., Retsch-Bogart, G. Z., & Montgomery, A. B. (2008). Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 178(9), 921–928. PubMedCrossRef
23.
go back to reference Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R., & Boucher, R. C. (2006). Mucus clearance and lung function in cystic fibrosis with hypertonic saline. New England Journal of Medicine, 354(3), 241–250. PubMedCrossRef Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R., & Boucher, R. C. (2006). Mucus clearance and lung function in cystic fibrosis with hypertonic saline. New England Journal of Medicine, 354(3), 241–250. PubMedCrossRef
24.
go back to reference Elkins, M. R., Robinson, M., Rose, B. R., Harbour, C., Moriarty, C. P., Marks, G. B., et al. (2006). A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine, 354(3), 229–240. PubMedCrossRef Elkins, M. R., Robinson, M., Rose, B. R., Harbour, C., Moriarty, C. P., Marks, G. B., et al. (2006). A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine, 354(3), 229–240. PubMedCrossRef
25.
go back to reference Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., et al. (2010). Effect of VX-770 in persons with cystic fibrosis and the G551D- CFTR mutation. New England Journal of Medicine, 363, 1991–2003. PubMedCrossRef Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., et al. (2010). Effect of VX-770 in persons with cystic fibrosis and the G551D- CFTR mutation. New England Journal of Medicine, 363, 1991–2003. PubMedCrossRef
26.
go back to reference Cystic Fibrosis Foundation. (2010). Cystic fibrosis foundation patient registry: 2009 annual data report. Bethesda, MD: Cystic Fibrosis Foundation. Cystic Fibrosis Foundation. (2010). Cystic fibrosis foundation patient registry: 2009 annual data report. Bethesda, MD: Cystic Fibrosis Foundation.
27.
go back to reference Ware, J. E., Brook, R. H., Davies-Avery, A. R., Williams, K. N., Stewart, A., Rogers, W. H., et al. (1980). Conceptualization and measurement of health for adults in the health insurance study: Vol. I, model of health and methodology. Rand Corporation, Santa Monica. Pub. no. R-1987/1-HEW. Ware, J. E., Brook, R. H., Davies-Avery, A. R., Williams, K. N., Stewart, A., Rogers, W. H., et al. (1980). Conceptualization and measurement of health for adults in the health insurance study: Vol. I, model of health and methodology. Rand Corporation, Santa Monica. Pub. no. R-1987/1-HEW.
28.
go back to reference Martin, J. L., Ford, C. B., Dyer-Friedman, J., Tang, J., & Huffman, L. C. (2004). Patterns of agreement between parent and child ratings of emotional and behavioral problems in an outpatient clinical setting: When children endorse more problems. Journal of Developmental and Behavioral Pediatrics, 25(3), 150–155. PubMedCrossRef Martin, J. L., Ford, C. B., Dyer-Friedman, J., Tang, J., & Huffman, L. C. (2004). Patterns of agreement between parent and child ratings of emotional and behavioral problems in an outpatient clinical setting: When children endorse more problems. Journal of Developmental and Behavioral Pediatrics, 25(3), 150–155. PubMedCrossRef
29.
go back to reference Levi, R., & Drotar, D. (1998). Measuring health-related quality of life in children and adolescents: implications for research and practice. Mahwah, NJ: Lawrence Erlbaum Associates Publishers. Levi, R., & Drotar, D. (1998). Measuring health-related quality of life in children and adolescents: implications for research and practice. Mahwah, NJ: Lawrence Erlbaum Associates Publishers.
30.
go back to reference Havermans, T., Vreys, M., Proesmans, M., & De Boeck, C. (2006). Assessment of agreement between parents and children on health-related quality of life in children with cystic fibrosis. Child: Care, Health and Development, 32(1), 1–7. CrossRef Havermans, T., Vreys, M., Proesmans, M., & De Boeck, C. (2006). Assessment of agreement between parents and children on health-related quality of life in children with cystic fibrosis. Child: Care, Health and Development, 32(1), 1–7. CrossRef
31.
go back to reference Schmidt, A., Wenninger, K., Niemann, N., Wahn, U., & Staab, D. (2009). Health-related quality of life in children with cystic fibrosis: Validation of the German CFQ-R. Health and Quality of Life Outcomes, 7, 97. PubMedCrossRef Schmidt, A., Wenninger, K., Niemann, N., Wahn, U., & Staab, D. (2009). Health-related quality of life in children with cystic fibrosis: Validation of the German CFQ-R. Health and Quality of Life Outcomes, 7, 97. PubMedCrossRef
32.
go back to reference Cruz, I., Marciel, K. K., Cheney, J., Wainwright, C., Campbell, M., & Quittner, A. L. (2009). The preschool cystic fibrosis questionnaire-revised: initial validation results. Pediatric Pulmonology, 32(Suppl), 421 (abstract). Cruz, I., Marciel, K. K., Cheney, J., Wainwright, C., Campbell, M., & Quittner, A. L. (2009). The preschool cystic fibrosis questionnaire-revised: initial validation results. Pediatric Pulmonology, 32(Suppl), 421 (abstract).
33.
go back to reference VanDevanter, D. R., Rasouliyan, L., Murphy, T. M., Morgan, W. J., Ren, C. L., Konstan, M. W., et al. (2008). Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005. Pediatric Pulmonology, 43(8), 739–744. PubMedCrossRef VanDevanter, D. R., Rasouliyan, L., Murphy, T. M., Morgan, W. J., Ren, C. L., Konstan, M. W., et al. (2008). Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005. Pediatric Pulmonology, 43(8), 739–744. PubMedCrossRef
Metagegevens
Titel
Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample
Auteurs
Alexandra L. Quittner
Gregory S. Sawicki
Ann McMullen
Lawrence Rasouliyan
David J. Pasta
Ashley Yegin
Michael W. Konstan
Publicatiedatum
01-09-2012
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 7/2012
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-0091-5